Vascular Endothelial Growth Factor (VEGF)-A165b Is a Weak In vitro Agonist for VEGF Receptor-2 Due to Lack of Coreceptor Binding and Deficient Regulation of Kinase Activity

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,162

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,661

VEGF receptor signalling ? in control of vascular function

Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122

Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor

Söker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,493

Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

Waltenberger, J. L., Claesson, L., Siegbahn, A., Shibuya, M., & Heldin, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,661

Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate

Esko, J. D., & Selleck, S. B. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135458 · Cited by 1,495

Neuropilin is a semaphorin III receptor.

Kolodkin, A., Levengood, D. V., Rowe, E. G., Tai, Y.-T., Giger, R., & Ginty, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80535-8 · Cited by 1,262

Neuropilin Is a Receptor for the Axonal Chemorepellent Semaphorin III

He, Z., & Tessier‐Lavigne, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80534-6 · Cited by 1,137

VEGF-receptor signal transduction

Cross, M. J., Dixelius, J., Matsumoto, T., & Claesson, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00193-2 · Cited by 890

Signal Transduction by Vascular Endothelial Growth Factor ReceptorsPreprint

Koch, S., Tugues, S., Li, X., Gualandi, L., & Claesson, L. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1042/bj20110301 · Cited by 1,710

Mechanisms and regulation of endothelial VEGF receptor signalling

Simons, M., Gordon, E., & Claesson-Welsh, L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.87 · Cited by 1,498

Molecular control of endothelial cell behaviour during blood vessel morphogenesis

Herbert, S. P., & Stainier, D. Y. R. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3176 · Cited by 1,082

Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedPreprint

David, C. J., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1973010 · Cited by 848

Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis

Sawamiphak, S., Seidel, S., Essmann, C. L., Wilkinson, G. A., Pitulescu, M. E., Acker, T., & Acker‐Palmer, A. (2010) · Nature · doi:10.1038/nature08995 · Cited by 551

Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2

Peach, C. J., Mignone, V. W., Arruda, M. A., Alcobia, D. C., Hill, S. J., Kilpatrick, L. E., & Woolard, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041264 · Cited by 533

VEGF-A splicing: the key to anti-angiogenic therapeutics?

Harper, S. J., & Bates, D. O. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2505 · Cited by 541

Biology and therapeutic targeting of vascular endothelial growth factor A

Pérez, L., & Ferrara, N. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00631-w · Cited by 540

Extracellular regulation of VEGF: Isoforms, proteolysis, and vascular patterning

Vempati, P., Popel, A. S., & Gabhann, F. M. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.11.002 · Cited by 319

Misregulation of Pre-mRNA Alternative Splicing in Cancer

Zhang, J., & Manley, J. L. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0253 · Cited by 316

WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing

Amin, E. M., Oltean, S., Hua, J., Gammons, M. V. R., Hamdollah‐Zadeh, M., Welsh, G. I., Cheung, M., Ni, L., Kase, S., Rennel, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.016 · Cited by 254

Structure and function of VEGF receptors

Stuttfeld, E., & Ballmer‐Hofer, K. (2009) · IUBMB Life · doi:10.1002/iub.234 · Cited by 253

VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level

Arcondéguy, T., Lacazette, É., Millevoi, S., Prats, H., & Touriol, C. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt539 · Cited by 256

Intrinsically disordered proteins play diverse roles in cell signaling

Bondos, S. E., Dunker, A. K., & Uversky, V. N. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00821-7 · Cited by 222

Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer

Tugues, S., Koch, S., Gualandi, L., Li, X., & Claesson, L. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.04.004 · Cited by 209

Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output

Ballmer‐Hofer, K., Andersson, A., Ratcliffe, L. E. K., & Berger, P. (2011) · Blood · doi:10.1182/blood-2011-01-328773 · Cited by 212

An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease

Kikuchi, R., Nakamura, K., MacLauchlan, S., Ngo, D. T. M., Shimizu, I., Fuster, J. J., Katanasaka, Y., Yoshida, S., Qiu, Y., Yamaguchi, T. P., et al. (2014) · Nature Medicine · doi:10.1038/nm.3703 · Cited by 201

The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy

Mabeta, P., & Steenkamp, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415585 · Cited by 192

VEGF receptor 2/‐3 heterodimers detected in situ by proximity ligation on angiogenic sprouts

Nilsson, I., Bahram, F., Li, X., Gualandi, L., Koch, S., Jarvius, M., Söderberg, O., Anisimov, A., Kholová, I., Pytowski, B., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.30 · Cited by 191

Mechanisms of resistance to antiangiogenesis therapy

Azam, F., Mehta, S., & Harris, A. L. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.020 · Cited by 188

Targeting VEGF in eye neovascularization: What's new?

Amadio, M., Govoni, S. M., & Pascale, A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.027 · Cited by 180

Structure–function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling

Grünewald, F. S., Prota, A. E., Giese, A., & Ballmer‐Hofer, K. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.002 · Cited by 164

Molecular Diversity of VEGF-A as a Regulator of Its Biological Activity

Woolard, J., Bevan, H. S., Harper, S. J., & Bates, D. O. (2009) · Microcirculation · doi:10.1080/10739680902997333 · Cited by 163

Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy

Oltean, S., Qiu, Y., Ferguson, J., Stevens, M., Neal, C., Russell, A., Kaura, A., Arkill, K. P., Harris, K., Symonds, C., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014040350 · Cited by 136

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis

Girolamo, F., Coppola, C., Ribatti, D., & Trojano, M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0084-z · Cited by 127

Antiangiogenic VEGF 165 b Regulates Macrophage Polarization via S100A8/S100A9 in Peripheral Artery Disease

Ganta, V. C., Choi, M., Farber, C. R., & Annex, B. H. (2019) · Circulation · doi:10.1161/circulationaha.118.034165 · Cited by 123

Vascular Growth Factors and Glomerular Disease

Bartlett, C. S., Jeansson, M., & Quaggin, S. E. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105412 · Cited by 117

VEGF-A165b Is an Endogenous Neuroprotective Splice Isoform of Vascular Endothelial Growth Factor A in Vivo and in Vitro

Beazley‐Long, N., Hua, J., Jehle, T., Hulse, R. P., Dersch, R. S., Lehrling, C., Bevan, H. S., Qiu, Y., Lagrèze, W. A., Wynick, D., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.05.031 · Cited by 121

Alternative Splicing in Angiogenesis

Bowler, E., & Oltean, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092067 · Cited by 111

The anti-angiogenic isoforms of VEGF in health and disease

Qiu, Y., Hoareau‐Aveilla, C., Oltean, S., Harper, S. J., & Bates, D. O. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371207 · Cited by 108

Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia

Hulse, R. P., Beazley‐Long, N., Hua, J., Kennedy, H. J., Prager, J., Bevan, H. S., Qiu, Y., Fernandes, E. S., Gammons, M. V. R., Ballmer‐Hofer, K., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.012 · Cited by 89

VEGF 165 b Modulates Endothelial VEGFR1–STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease

Ganta, V. C., Choi, M., Kutateladze, A. A., & Annex, B. H. (2016) · Circulation Research · doi:10.1161/circresaha.116.309516 · Cited by 92

VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer

Biselli-Chicote, P. M., Oliveira, A. R. C. P., Pavarino, É. C., & Goloni‐Bertollo, E. M. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1073-2 · Cited by 93

VEGF-A 165 b Is Cytoprotective and Antiangiogenic in the Retina

Magnussen, A., Rennel, E., Hua, J., Bevan, H. S., Beazley‐Long, N., Lehrling, C., Gammons, M. V. R., Floege, J., Harper, S. J., Agostini, H. T., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4296 · Cited by 86

The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo

Merdzhanova, G., Gout, S., Kéramidas, M., Edmond, V., Coll, J., Brambilla, C., Brambilla, E. M., Gazzéri, S., & Eymin, B. (2010) · Oncogene · doi:10.1038/onc.2010.281 · Cited by 84

The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling

Mattila, E., Auvinen, K., Salmi, M., & Ivaska, J. (2008) · Journal of Cell Science · doi:10.1242/jcs.031898 · Cited by 82

Evidence for Pro-angiogenic Functions of VEGF-Ax

Xin, H., Zhong, C., Nudleman, E., & Ferrara, N. (2016) · Cell · doi:10.1016/j.cell.2016.08.054 · Cited by 80

VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A

Catena, R., Larzábal, L., Larráyoz, M., Molina, E., Hermida, J., Agorreta, J., Montes, R., Pı́o, R., Montuenga, L. M., & Calvo, A. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-320 · Cited by 79

How VEGF-A and its splice variants affect breast cancer development – clinical implications

Kawas, H. A., Saaid, I., Jank, P., Westhoff, C. C., Denkert, C., Pross, T., Weiler, K. B. S., & Karsten, M. M. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00665-w · Cited by 72

Wnt5a and its signaling pathway in angiogenesis

Shi, Y., Zhu, N., Liu, C., Wu, H., Gui, Y., Liao, D., & Li, Q. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.06.017 · Cited by 73

Therapeutic angiogenesis-based strategy for peripheral artery disease

Han, J., Luo, L., Marcelina, O., Kasim, V., & Wu, S. (2022) · Theranostics · doi:10.7150/thno.74785 · Cited by 77

Splicing in oncogenesis and tumor suppression

Kaida, D., Schneider‐Poetsch, T., & Yoshida, M. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02356.x · Cited by 71

VEGF Receptor Tyrosine Kinases

Álvarez-Aznar, A., Muhl, L., & Gaengel, K. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.10.001 · Cited by 66

Antiangiogenic Therapy for Diabetic Nephropathy

Tanabe, K., Maeshima, Y., Sato, Y., & Wada, J. (2017) · BioMed Research International · doi:10.1155/2017/5724069 · Cited by 67

The balance of proangiogenic and antiangiogenic VEGFA isoforms regulate follicle development

McFee, R. M., Rozell, T. G., & Cupp, A. S. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1330-y · Cited by 64

New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation

Delcombel, R., Janssen, L., Vassy, R., Gammons, M. V. R., Haddad, O., Richard, B., Letourneur, D., Bates, D. O., Hendricks, C., Waltenberger, J. L., et al. (2012) · Angiogenesis · doi:10.1007/s10456-012-9320-y · Cited by 64

VEGF-A isoforms program differential VEGFR2 signal transduction, trafficking and proteolysis

Fearnley, G. W., Smith, G. A., Abdul‐Zani, I., Yuldasheva, N. Y., Mughal, N. A., Homer‐Vanniasinkam, S., Kearney, M. T., Zachary, I. C., Tomlinson, D. C., Harrison, M. A., et al. (2016) · Biology Open · doi:10.1242/bio.017434 · Cited by 62

Abnormal Histone Methylation Is Responsible for Increased Vascular Endothelial Growth Factor 165a Secretion from Airway Smooth Muscle Cells in Asthma

Clifford, R. L., John, A. E., Brightling, C. E., & Knox, A. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103641 · Cited by 61

Impaired Angiogenesis in Systemic Sclerosis: The Emerging Role of the Antiangiogenic VEGF165b Splice Variant

Manetti, M., Guiducci, S., Ibba‐Manneschi, L., & Matucci‐Cerinic, M. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.05.011 · Cited by 62

Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src

Sjöberg, E., Melssen, M. M., Richards, M., Ding, Y., Chanoca, C., Chen, D., Nwadozi, E., Pal, S., Love, D. T., Ninchoji, T., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci161366 · Cited by 58

Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis

Stevens, M., & Oltean, S. (2019) · Cells · doi:10.3390/cells8040288 · Cited by 58

VEGF-A splice variants bind VEGFRs with differential affinities

Mamer, S. B., Wittenkeller, A., & Imoukhuede, P. I. (2020) · Scientific Reports · doi:10.1038/s41598-020-71484-y · Cited by 55

Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model

Clegg, L. E., & Gabhann, F. M. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004158 · Cited by 58

The role of VEGF165b in pathophysiology

Peiris‐Pagès, M. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.22439 · Cited by 55

VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop

Boudria, A., Abou Faycal, C., Jia, T., Gout, S., Keramidas, M., Didier, C., Lemaître, N., Manet, S., Coll, J.-L., Toffart, A.-C., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0486-7 · Cited by 53

Real-time analysis of the binding of fluorescent VEGF 165 a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexes

Kilpatrick, L. E., Ohana, R. F., Alcobia, D. C., Riching, K. M., Peach, C. J., Wheal, A. J., Briddon, S. J., Robers, M. B., Zimmerman, K., Machleidt, T., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.006 · Cited by 53

The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor

Friedli, A., Fischer, E., Novak‐Hofer, I., Cohrs, S., Ballmer‐Hofer, K., Schubiger, P. A., Schibli, R., & Grünberg, J. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.01.006 · Cited by 52

Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis

Romano, E., Chora, I., Manetti, M., Mazzotta, C., Rosa, I., Bellando-Randone, S., Blagojević, J., Soares, R. A., Avouac, J., Allanore, Y., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207483 · Cited by 51

Do Anti-Angiogenic VEGF (VEGFxxxb) Isoforms Exist? A Cautionary Tale

Harris, S., Craze, M. L., Newton, J., Fisher, M. L., Shima, D. T., Tozer, G. M., & Kanthou, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035231 · Cited by 51

Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy

Fayçal, C. A., Hatat, A., Gazzéri, S., & Eymin, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020383 · Cited by 55

Mechanisms regulating angiogenesis underlie seasonal control of pituitary function

Castle-Miller, J., Bates, D. O., & Tortonese, D. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618917114 · Cited by 50

VEGFA165 gene therapy ameliorates blood-labyrinth barrier breakdown and hearing loss

Zhang, J., Hou, Z., Wang, X., Jiang, H., Neng, L., Zhang, Y., Yu, Q. T., Burwood, G., Song, J., Auer, M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.143285 · Cited by 53

VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo

Rennel, E. S., Varey, A. H. R., Churchill, A. J., Wheatley, E. R., Stewart, L., Mather, S. J., Bates, D. O., & Harper, S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605249 · Cited by 48

BDNF (Brain-Derived Neurotrophic Factor) Promotes Embryonic Stem Cells Differentiation to Endothelial Cells Via a Molecular Pathway, Including MicroRNA-214, EZH2 (Enhancer of Zeste Homolog 2), and eNOS (Endothelial Nitric Oxide Synthase)

Descamps, B., Saif, J., Benest, A. V., Biglino, G., Bates, D. O., Chamorro-Jorganes, A., & Emanueli, C. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311400 · Cited by 47

An unexpected tail of VEGF and PlGF in pre-eclampsia

Bates, D. O. (2011) · Biochemical Society Transactions · doi:10.1042/bst20110671 · Cited by 44

VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing

Guyot, M., & Pagès, G. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2917-7_1 · Cited by 43

The role of neuropilins in cell signalling

Zachary, I. C., Frankel, P., Evans, I. M., & Pellet‐Many, C. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371171 · Cited by 43

Overexpression of VEGF165b in Podocytes Reduces Glomerular Permeability

Qiu, Y., Ferguson, J., Oltean, S., Neal, C., Kaura, A., Bevan, H. S., Wood, E., Sage, L. M., Lanati, S., Nowak, D. G., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060617 · Cited by 42

VEGF in the lung: a role for novel isoforms

Varet, J., Douglas, S. K., Gilmartin, L., Medford, A. R. L., Bates, D. O., Harper, S. J., & Millar, A. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00353.2009 · Cited by 41

Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease

Stevens, M., & Oltean, S. (2018) · Genes · doi:10.3390/genes9020098 · Cited by 41

Coordination of VEGF receptor trafficking and signaling by coreceptors

Nakayama, M., & Berger, P. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.008 · Cited by 40

Real-Time Ligand Binding of Fluorescent VEGF-A Isoforms that Discriminate between VEGFR2 and NRP1 in Living Cells

Peach, C. J., Kilpatrick, L. E., Ohana, R. F., Zimmerman, K., Robers, M. B., Wood, K. V., Woolard, J., & Hill, S. J. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.06.012 · Cited by 39

VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cells

Ourradi, K., Blythe, T., Jarrett, C., Barratt, S. L., Welsh, G. I., & Millar, A. (2017) · Respiratory Research · doi:10.1186/s12931-017-0602-1 · Cited by 38

VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritis

Beazley‐Long, N., Hodge, D., Ashby, W. R., Bestall, S. M., Almahasneh, F. A., Durrant, A. M., Benest, A. V., Blackley, Z., Ballmer‐Hofer, K., Hirashima, M., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.012 · Cited by 38

Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis

Kim, Y., Bae, J., Shin, T.-H., Kang, S. H., Jeong, M., Han, Y., Park, J., Kim, S.-K., & Kim, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.016 · Cited by 35

Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-A165a, VEGF-A165b, PIGF and VE-cadherin

Pang, V., Bates, D. O., & Leach, L. (2017) · Clinical Science · doi:10.1042/cs20171252 · Cited by 34

VEGF-A121a binding to Neuropilins – A concept revisited

Sarabipour, S., & Gabhann, F. M. (2017) · Cell Adhesion & Migration · doi:10.1080/19336918.2017.1372878 · Cited by 32

Conformational remodeling of the fibronectin matrix selectively regulates VEGF signaling

Ambesi, A., & McKeown‐Longo, P. J. (2014) · Journal of Cell Science · doi:10.1242/jcs.150458 · Cited by 32

Vascular endothelial growth factor A: just one of multiple mechanisms for sex-specific vascular development within the testis?

Sargent, K. M., McFee, R. M., Gomes, R. S., & Cupp, A. S. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0342 · Cited by 35

Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators

Bates, D. O., Beazley‐Long, N., Benest, A. V., Ye, X., Ved, N., Hulse, R. P., Barratt, S. L., Machado, M. J. C., Donaldson, L. F., Harper, S. J., et al. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170015 · Cited by 36

Dynamics and implications of circulating anti-angiogenic VEGF-A165b isoform in patients with ST-elevation myocardial infarction

Hueso, L., Ríos‐Navarro, C., Ruiz‐Saurí, A., Chorro, F. J., Núñez, J. E., Sanz, M., Bodı́, V., & Piqueras, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-10505-9 · Cited by 31

VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment

Karsten, M. M., Beck, M. H., Rademacher, A., Knabl, J., Blohmer, J., Jückstöck, J., Radosa, J. C., Jank, P., Rack, B. K., & Janni, W. (2020) · Scientific Reports · doi:10.1038/s41598-020-59823-5 · Cited by 31

Role of small interfering RNA (siRNA) in targeting ocular neovascularization: A review

Supe, S., Upadhya, A., & Singh, K. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108329 · Cited by 31

Therapeutic Potential of Manipulating VEGF Splice Isoforms in Oncology

Rennel, E., Harper, S. J., & Bates, D. O. (2009) · Future Oncology · doi:10.2217/fon.09.33 · Cited by 32

VEGFA splicing: divergent isoforms regulate spermatogonial stem cell maintenance

Sargent, K. M., Clopton, D. T., Lu, N., Pohlmeier, W. E., & Cupp, A. S. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2297-2 · Cited by 30

Altered ratios of pro‐ and anti‐angiogenic VEGF ‐A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangioma

Ye, X., Abou-Rayyah, Y., Bischoff, J. E., Ritchie, A., Sebire, N. J., Watts, P., Churchill, A., & Bates, D. O. (2016) · The Journal of Pathology · doi:10.1002/path.4715 · Cited by 29

Bevacizumab and intraocular tumors: an intriguing paradox.

el Filali, M., Ly, L. V., Luyten, G. P. M., Versluis, M., Grossniklaus, H. E., van der Velden, P. A., & Jager, M. J. (2012) · PubMed Central · Cited by 29

Vascular endothelial growth factor receptors and the therapeutic targeting of angiogenesis in cancer: where do we go from here?

Bruce, D. J., & Tan, P. (2011) · Cell Communication & Adhesion · doi:10.3109/15419061.2011.619673 · Cited by 27

VEGFR‐2‐mediated increased proliferation and survival in response to oxygen and glucose deprivation in PlGF knockout astrocytes

Freitas-Andrade, M., Carmeliet, P., Stanimirovic, D., & Moreno, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05660.x · Cited by 31

Growth of Uveal Melanoma following Intravitreal Bevacizumab

Francis, J. H., Kim, J. W., Lin, A., Folberg, R., Iyer, S., & Abramson, D. H. (2016) · Ocular Oncology and Pathology · doi:10.1159/000450859 · Cited by 27

Mediators involved in retinopathy of prematurity and emerging therapeutic targets

Mataftsi, A., Dimitrakos, S. A., & Adams, G. G. W. (2011) · Early Human Development · doi:10.1016/j.earlhumdev.2011.05.009 · Cited by 27

VEGF-A isoform-specific regulation of calcium ion flux, transcriptional activation and endothelial cell migration

Fearnley, G. W., Bruns, A. F., Wheatcroft, S. B., & Ponnambalam, S. (2015) · Biology Open · doi:10.1242/bio.201410884 · Cited by 27

Vascular Endothelial Growth Factor and Other Angioglioneurins

Lafuente, J. V., Ortuzar, N., Bengoetxea, H., Bulnes, S., & Argandoña, E. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00012-0 · Cited by 27

Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis

Chen, Y., Tai, Z., Zhu, C., Qin, Y., Zhu, Q., & Chen, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010059 · Cited by 29

Peripheral vascular disease: preclinical models and emerging therapeutic targeting of the vascular endothelial growth factor ligand-receptor system

Ganta, V. C., & Annex, B. H. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1940139 · Cited by 24

Receptor tyrosine kinase structure and function in health and disease

Karpov, O. A., Fearnley, G. W., Smith, G. A., Kankanala, J., McPherson, M. J., Tomlinson, D. C., Harrison, M. A., & Ponnambalam, S. (2015) · AIMS Biophysics · doi:10.3934/biophy.2015.4.476 · Cited by 26

Enhanced vascular endothelial growth factor signaling in islets contributes to β cell injury and consequential diabetes in spontaneously diabetic Torii rats

Mukai, E., Ohta, T., Kawamura, H., Lee, E.-Y., Morita, A., Sasase, T., Miyajima, K., Inagaki, N., Iwanaga, T., & Miki, T. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.023 · Cited by 24

Functional effects of blocking VEGF/VEGFR2 signaling in the rat urinary bladder in acute and chronic CYP-induced cystitis

Tooke, K., Girard, B. M., & Vizzard, M. A. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00083.2019 · Cited by 24

Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomy

Zhuang, P., Wang, J., Tang, Z., Zhou, X.-P., Yang, Y., Quan, Z.-W., Liu, Y., & Shen, J. (2014) · Oncotarget · doi:10.18632/oncotarget.2553 · Cited by 23

Claesson-Welsh L: Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity

Kawamura, H., Li, X., Harper, S. J., Al, E., Aacr, C. T., Kawamura, H., Li, X., Harper, S. J., Bates, D. O., & Claesson‐Welsh, L. (2013)

A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2

Suarez, S., Pieren, M., Cariolato, L., Arn, S., Hoffmann, U., Bogucki, A., Manlius, C., Wood, J. M., & Ballmer‐Hofer, K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6254-9 · Cited by 208

VEGF-A splice variants bind VEGFRs with differential affinities

Mamer, S. B., Wittenkeller, A., & Imoukhuede, P. I. (2020) · Scientific Reports · doi:10.1038/s41598-020-71484-y · Cited by 55

Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization

Kawamura, H., Li, X., Goishi, K., van Meeteren, L. A., Jakobsson, L., Suarez, S., Shimizu, A., Edholm, D., Ballmer‐Hofer, K., Kjellén, L., et al. (2008) · Blood · doi:10.1182/blood-2007-12-125856 · Cited by 177

Vascular Endothelial Growth Factor Receptor-2 and Neuropilin-1 Form a Receptor Complex That Is Responsible for the Differential Signaling Potency of VEGF165 and VEGF121

Whitaker, G. B., Limberg, B. J., & Rosenbaum, J. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102315200 · Cited by 299